CCNYL1 抗体 (AA 51-99)
Quick Overview for CCNYL1 抗体 (AA 51-99) (ABIN6751550)
抗原
See all CCNYL1 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 51-99
- 
                                            特异性
- Human CCNYL1
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- 
                        Synthetic peptide located between aa51-99 of human CCNYL1 (Q8N7R7-2). Percent identity by BLAST analysis: Human, Chimpanzee (100%).
 Type of Immunogen: Synthetic peptide
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            溶解方式
- Distilled water
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Lyophilized from PBS
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- 
                        Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
 Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
 
- 
                                            
- 
    - CCNYL1 (Cyclin Y-Like 1 (CCNYL1))
- 
                                            别名
- CCNYL1
- 
                                            背景
- 
                        Name/Gene ID: CCNYL1
 Synonyms: CCNYL1, Cyclin Y-like 1, Cyclin-Y-like protein 1
- 
                                            基因ID
- 151195
- 
                                            UniProt
- Q8N7R7
 抗原
- 
                    
 
                                     
                                     
                                    